The Gut Health Protocol is the first in a planned series of specialised protocols that will extend Project Serotonin’s precision platform into specific health domains to function as therapy adjuncts. These protocols, unique to the Platform, are built using first principles and genetics-first, whole system approaches. All variables are considered, including genetics, blood and urine biomarkers, diet, age, gender and lifestyle that may affect related health outcomes. These highly precise and personalized protocols follow rigorous, real-world pilots for efficacy and usability before release. Further, these are continuously optimized for every user journey, and have outcomes that are measurable and trackable longitudinally.
Project Serotonin’s Gut Health Protocol identifies an individual’s inherited predispositions to digestive conditions, then validates and contextualizes them through biomarker data. This integrated view enables personalized interventions, e.g. foods to avoid or include, supplements that must be added to the diet to address underlying biological drivers rather than symptoms alone. Recommendations are continuously refined as new data is collected, functioning as a precision therapy adjunct alongside clinical care.
Explaining the approach adopted by Project Serotonin’s Gut Health Protocol, Dr Ashwat Visvanathan (PhD), Head – Partnerships and User Outcomes, Project Serotonin said. “Our proprietary genetic models decode how your body is fundamentally wired, enabling us to correct gut-related issues through highly precise, personalized interventions across diet, supplements, and lifestyle. Smiles Institute of Gastroenterology’s decision to deploy the platform across its patient care pathways reflects a growing recognition among leading clinical institutions that precision foundational health when integrated into the treatment journey can meaningfully improve patient experience and long-term outcomes.”
Speaking on the association with Project Serotonin, Dr CM Parameshwara, CEO & Founder, Smiles Institute of Gastroenterology said, “What drew us to Project Serotonin’s platform is the rigour of their approach starting from genetic predisposition, validating through biomarkers, and building corrective strategies that complement the clinical interventions we provide. Deploying this within our patient care pathways allows us, for the first time, to offer a precision, data-driven layer of foundational health optimisation that works alongside treatment and meaningfully improves the patient journey. By deploying Project Serotonin’s platform, we have gained access to a first-of-its-kind precision health infrastructure that has been built and refined over a decade.”
Despite growing prevalence of significant genetic predispositions for gut related conditions around the world, most approaches to gut health remain reactive, treating symptoms after they manifest rather than addressing biological root causes. Imbalances in the gut have been known to have significant downstream effects affecting mental health, thyroid health, skin and hair health and immune health. Moreover, there is a significant overlap of symptoms across different gut health conditions, making the diagnosis of these conditions even more complicated.
About Project Serotonin
Built over ten years of R&D, with conviction that peak health can be achieved with precision science and cutting edge technology, Project Serotonin’s eighth generation platform is powered by deep-learning algorithms that integrate genetics, blood biomarkers, nutrition, lifestyle, wearable data and behavioral metrics. The company runs extensive real-world pilots for every protocol before release and continuously optimizes outcomes for every single user.
Its multidisciplinary team of scientists and engineers have invested over 300,000 hours to precisely quantify micronutrients – exact formulations, dosages, frequency, combinations, exercise, sleep, fasting, diet, and lifestyle protocols that deliver precision results. Project Serotonin’s mission is to make measurable, outcomes-guaranteed peak health accessible to millions through trusted partners. For more information, visit: www.projectserotonin.com
About Smiles Institute of Gastroenterology Built on a foundation of clinical excellence and advanced surgical innovation, Smiles Institute of Gastroenterology has emerged as a leading center for minimally invasive gastroenterological care in India. With a specialized focus on conditions such as piles, fissures, fistula, and other colorectal disorders, the hospital combines state-of-the-art laser technology with evidence-based medical protocols to deliver precise, effective, and patient-centric outcomes. Backed by a team of highly experienced gastroenterologists and surgeons, Smiles Hospitals emphasizes accurate diagnosis, minimal downtime procedures, and comprehensive post-treatment care. The institution continuously refines its clinical approaches through real-world patient outcomes, ensuring consistent improvements in safety, recovery, and long-term results. Committed to making advanced gastrointestinal care accessible and reliable, Smiles Hospitals aims to set new benchmarks in treatment quality and patient experience across India. For more information, visit: https://gastroenterology.smileshospitals.com
If you object to the content of this press release, please notify us at pr.error.rectification@gmail.com. We will respond and rectify the situation within 24 hours.
